Clinical Trial Update: Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial comparing atezolizumab/bevacizumab versus neoadjuvant radiation therapy in hepatocellular carcinoma with portal vein thrombosis has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Portal Vein Thrombosis

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Hepatocellular Carcinoma, Portal Vein Tumour Thrombosis | Phase 2 | Status: TERMINATED